875237-68-6

Basic information

• Product Name: 5-(2-Oxo-hexahydro-thieno[3,4-d]iMidazol-6-yl)-pentanoic acid Methyl ester
• Synonyms: 5-(2-Oxo-hexahydro-thieno[3,4-d]iMidazol-6-yl)-pentanoic acid Methyl ester;Methyl 5-(2-oxohexahydro-1H-thieno[3,4-d]iMidazol-4-yl)pentanoate
• CAS NO: 875237-68-6
• Molecular Formula: C₁₁H₁₈N₂O₃S
• Molecular Weight: 258.33722
• Mol File: 875237-68-6.mol

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 5-(2-Oxo-hexahydro-thieno[3,4-d]iMidazol-6-yl)-pentanoic acid Methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 5-(2-Oxo-hexahydro-thieno[3,4-d]iMidazol-6-yl)-pentanoic acid Methyl ester(875237-68-6)
• EPA Substance Registry System: 5-(2-Oxo-hexahydro-thieno[3,4-d]iMidazol-6-yl)-pentanoic acid Methyl ester(875237-68-6)

Safety Data

• Hazardous Substances Data: 875237-68-6(Hazardous Substances Data)

Upstream product

• 67-56-1 methanol 
• 4443-68-9 biotin 

Relevant articles and documents

Biotin derivatives, methods for making same and uses thereof as vectors

The invention concerns biotin derivatives of general formula (I), wherein: R1 represents a specific compound; X1 represents a carbonaceous chain, preferably of 1 to 10 carbon atoms, substituted or not, optionally comprising one or several carbonyl or oxycarbonyl groups, and/or a —NH— group, in particular a chain of formula —HN(CH2)n—O—CO wherein n is an integer between 1 and 5 and optionally comprising one or several ether, amide and/or amino functions; Y represents a hydrocarbon chain of 1 to 5 carbon atoms, substituted or not; R2 represents a hydrogen atom, or a protecting group, in particular R2 represents an alkyl group of 1 to 5 carbon atoms. The invention is useful as vectors, in particular for implementing methods for detecting interactions between biological compounds, and in pharmaceutical compositions.

Synthesis of biotin

A novel process for the preparation of biotin is disclosed wherein said process employs inexpensive starting materials and reagents resulting in the obtention of biotin devoid of the biologically inactive stereoisomers.